Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT)’s share price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $2.89. Xtant Medical shares last traded at $2.89, with a volume of 1,524 shares.

Separately, Maxim Group set a $25.00 target price on shares of Agilysys and gave the stock a “buy” rating in a report on Friday, May 17th.

Xtant Medical (NYSEAMERICAN:XTNT) last posted its quarterly earnings results on Wednesday, May 15th. The medical device company reported ($0.21) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.36) by $0.15. The business had revenue of $16.73 million during the quarter.

A hedge fund recently raised its stake in Xtant Medical stock. Telemetry Investments L.L.C. boosted its holdings in Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) by 8.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 796,826 shares of the medical device company’s stock after purchasing an additional 63,079 shares during the quarter. Xtant Medical makes up approximately 0.8% of Telemetry Investments L.L.C.’s holdings, making the stock its 25th biggest position. Telemetry Investments L.L.C. owned 6.05% of Xtant Medical worth $1,283,000 as of its most recent SEC filing.

About Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.

Featured Article: Oversold

Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.